Literature DB >> 29407413

Exacerbation of sensorimotor dysfunction in mice deficient in Atp13a2 and overexpressing human wildtype alpha-synuclein.

Emily R Dirr1, Osunde R Ekhator1, Rachel Blackwood1, John G Holden1, Eliezer Masliah2, Patrick J Schultheis3, Sheila M Fleming4.   

Abstract

Loss of function mutations in the gene ATP13A2 are associated with Kufor-Rakeb Syndrome and Neuronal Ceroid Lipofuscinosis, the former designated as an inherited form of Parkinson's disease (PD). The function of ATP13A2 is unclear but in vitro studies indicate it is a lysosomal protein and may interact with the presynaptic protein alpha-synuclein (aSyn) and certain heavy metals. Accumulation of aSyn is a major component of lewy bodies, the pathological hallmark of PD. Atp13a2-deficient (13a2) mice develop age-dependent sensorimotor deficits, and accumulation of insoluble aSyn in the brain. To better understand the interaction between ATP13A2 and aSyn, double mutant mice with loss of Atp13a2 function combined with overexpression of human wildtype aSyn were generated. Female and male wildtype (WT), 13a2, aSyn, and 13a2-aSyn mice were tested on a battery of sensorimotor tests including adhesive removal, challenging beam traversal, spontaneous activity, gait, locomotor activity, and nest-building at 2, 4, and 6 months of age. Double mutant mice showed an earlier onset and accelerated alterations in sensorimotor function that were age, sex and test-dependent. Female 13a2-aSyn mice showed early and progressive dysfunction on the beam and in locomotor activity. In males, 13a2-aSyn mice showed more severe impairments in spontaneous activity and adhesive removal. Sex differences were also observed in aSyn and 13a2-aSyn mice on the beam, cylinder, and adhesive removal tests. In other tasks, double mutant mice displayed deficits similar to aSyn mice. These results indicate loss of Atp13a2 function exacerbates the sensorimotor phenotype in aSyn mice in an age and sex-dependent manner.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATP13A2; Alpha-synuclein; Mice; Phenotype; Sensorimotor

Mesh:

Substances:

Year:  2018        PMID: 29407413      PMCID: PMC5829010          DOI: 10.1016/j.bbr.2018.01.029

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  64 in total

1.  Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease.

Authors:  Eleni Antzoulatos; Michael W Jakowec; Giselle M Petzinger; Ruth I Wood
Journal:  Pharmacol Biochem Behav       Date:  2010-03-27       Impact factor: 3.533

2.  Identification of novel ATP13A2 interactors and their role in α-synuclein misfolding and toxicity.

Authors:  Marija Usenovic; Adam L Knight; Arpita Ray; Victoria Wong; Kevin R Brown; Guy A Caldwell; Kim A Caldwell; Igor Stagljar; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2012-05-29       Impact factor: 6.150

3.  Alpha-synuclein overexpression in mice alters synaptic communication in the corticostriatal pathway.

Authors:  Nanping Wu; Prasad R Joshi; Carlos Cepeda; Eliezer Masliah; Michael S Levine
Journal:  J Neurosci Res       Date:  2010-06       Impact factor: 4.164

4.  Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein.

Authors:  S M Fleming; J Salcedo; C B Hutson; E Rockenstein; E Masliah; M S Levine; M-F Chesselet
Journal:  Neuroscience       Date:  2006-08-23       Impact factor: 3.590

5.  Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).

Authors:  Alejandro Estrada-Cuzcano; Shaun Martin; Teodora Chamova; Matthis Synofzik; Dagmar Timmann; Tine Holemans; Albena Andreeva; Jennifer Reichbauer; Riet De Rycke; Dae-In Chang; Sarah van Veen; Jean Samuel; Ludger Schöls; Thorsten Pöppel; Danny Mollerup Sørensen; Bob Asselbergh; Christine Klein; Stephan Zuchner; Albena Jordanova; Peter Vangheluwe; Ivailo Tournev; Rebecca Schüle
Journal:  Brain       Date:  2017-02       Impact factor: 13.501

6.  Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.

Authors:  Ira E Clark; Mark W Dodson; Changan Jiang; Joseph H Cao; Jun R Huh; Jae Hong Seol; Soon Ji Yoo; Bruce A Hay; Ming Guo
Journal:  Nature       Date:  2006-05-03       Impact factor: 49.962

Review 7.  Genetic mouse models of parkinsonism: strengths and limitations.

Authors:  Sheila M Fleming; Pierre-Olivier Fernagut; Marie-Françoise Chesselet
Journal:  NeuroRx       Date:  2005-07

8.  α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9).

Authors:  Guillaume Daniel; Alessandra Musso; Elpida Tsika; Aris Fiser; Liliane Glauser; Olga Pletnikova; Bernard L Schneider; Darren J Moore
Journal:  Neurobiol Dis       Date:  2014-10-18       Impact factor: 5.996

Review 9.  A progressive mouse model of Parkinson's disease: the Thy1-aSyn ("Line 61") mice.

Authors:  Marie-Francoise Chesselet; Franziska Richter; Chunni Zhu; Iddo Magen; Melanie B Watson; Sudhakar R Subramaniam
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

10.  ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.

Authors:  A Di Fonzo; H F Chien; M Socal; S Giraudo; C Tassorelli; G Iliceto; G Fabbrini; R Marconi; E Fincati; G Abbruzzese; P Marini; F Squitieri; M W Horstink; P Montagna; A Dalla Libera; F Stocchi; S Goldwurm; J J Ferreira; G Meco; E Martignoni; L Lopiano; L B Jardim; B A Oostra; E R Barbosa; V Bonifati
Journal:  Neurology       Date:  2007-05-08       Impact factor: 9.910

View more
  5 in total

1.  Developmental exposure to the organochlorine pesticide dieldrin causes male-specific exacerbation of α-synuclein-preformed fibril-induced toxicity and motor deficits.

Authors:  Aysegul O Gezer; Joseph Kochmanski; Sarah E VanOeveren; Allyson Cole-Strauss; Christopher J Kemp; Joseph R Patterson; Kathryn M Miller; Nathan C Kuhn; Danielle E Herman; Alyssa McIntire; Jack W Lipton; Kelvin C Luk; Sheila M Fleming; Caryl E Sortwell; Alison I Bernstein
Journal:  Neurobiol Dis       Date:  2020-05-15       Impact factor: 5.996

2.  Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.

Authors:  Jessica M Froula; Marta Castellana-Cruz; Nadia M Anabtawi; José D Camino; Serene W Chen; Drake R Thrasher; Jennifer Freire; Allen A Yazdi; Sheila Fleming; Christopher M Dobson; Janet R Kumita; Nunilo Cremades; Laura A Volpicelli-Daley
Journal:  J Biol Chem       Date:  2019-05-29       Impact factor: 5.157

3.  Tyrosine Hydroxylase Inhibition in Substantia Nigra Decreases Movement Frequency.

Authors:  Michael F Salvatore; Tamara R McInnis; Mark A Cantu; Deana M Apple; Brandon S Pruett
Journal:  Mol Neurobiol       Date:  2018-07-28       Impact factor: 5.590

4.  ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization.

Authors:  Jianmin Si; Chris Van den Haute; Evy Lobbestael; Shaun Martin; Sarah van Veen; Peter Vangheluwe; Veerle Baekelandt
Journal:  Int J Mol Sci       Date:  2021-03-07       Impact factor: 5.923

Review 5.  The Emerging Role of the Lysosome in Parkinson's Disease.

Authors:  Alba Navarro-Romero; Marta Montpeyó; Marta Martinez-Vicente
Journal:  Cells       Date:  2020-11-02       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.